Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This study assesses dopamine transporter density using single photon emission computed
tomography (SPECT) brain imaging with an investigational radiopharmaceutical, [123I]ß-CIT, in
research participants with Parkinson's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborators:
Molecular NeuroImaging National Institutes of Health (NIH)